The modified Glasgow prognostic score may predict prognostic and therapy outcomes in patients with metastatic renal cell carcinoma
1. Baseline mGPS measures reliably predict the prognostic outcome of treatment in patients with metastatic renal cell carcinoma (mRCC) 2. ...